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CHAPTER lL REFERENCES
SUMMARY
Mouse CP2 is the founding member of a group of highly conserved proteins in
mouse, human, chicken and Drosophila collectively referred to as the CP2 family of
transcription factors. CP2 was originally identified in murine erythroleukemia (MEL)
cell nuclear extracts as an activator of the mouse a-globin gene, binding a promoter
element overlapping the CCAAT box. In addition Io CP2, the family includes mouse
NF2d9, human LBP-1c and LBPla, homologues of mouse CP2 and NF2d9
respectively, LBP-9, chicken CPZ and Drosophilø melønogaster CP2. Mammalian
CP2-related proteins have generally been shown to be activators of transcription and
expressed ubiquitously. There is little knowledge of factors that regulate their activity.
This thesis describes CRTR-I, a novel member of the CP2 famlly, originally
identified as a transcript differentially expressed between mouse ES and early primitive
ectoderm-like (EPL) cells in vitro. In vivo expression analysis showed CRTR-I to be
expressed by the pluripotent inner cell mass cells of the blastocyst, but not in the later
pluripotent cells of the primitive ectoderm. Analysis during later stages of development
and in the adult mouse showed CRTR-1 expression to be developmentally and spatially
regulated. Greatest levels of CRTR-I expression were detected in the embryonic and
adult kidneys with CRTR-I specifically expressed in the branching ureteric buds of the
developing kidney with expression becoming restricted to the epithelial lining of the
distal convoluted tubules during later kidney development and in the adult mouse.
These sites of CRTR-I expression suggest distinct biological roles for CRTR-I
function in the maintenance of pluripotency in the early stage embryo and in the
development and function of the kidney.
Conseruation in nucleotide and amino acid sequence defined CRTR-I as a
novel member of the mouse CP2 family of transcription factors. Consistent with this,
CRTR-1 was shown to interact with all other members of the mouse CP2 fanily,
forming protein complexes competent to bind a CP2 family consensus DNA response
element. However, unlike other CP2 family members, CRTR-I was shown to act as a
transcriptional repressor with the ability to repress transcription localised to a novel 52
amino acid N-terminal repression domain. Furthermore, the ability of CRTR-I to
repress transcription \ryas shown to be dominant over CP2 mediated transcriptional
activation. CRTR-I is therefore distinct from other family members in two respects,
CRTR-I expression is spatially and temporally regulated and CRTR-I acts as a
dominant transcriptional repressor of CP2 family mediated transcriptional activation.
This thesis also describes the identification, isolation and functional
characterisation of an alternatively spliced isoform of CP2, altCP2. Similar to CRTR-1,
altCP2 appears to be differentially expressed and was demonstrated to act as a
dominant repressor of CP2 family mediated transcriptional activation by formation of
heteromultimers with other CP2 familv proteins that cannot bind DNA. Together,
altCP2 and CRTR-1 provide mechanisms to achieve spatially and temporally regulated
activity of ubiquitously expressed CP2 family transcriptional activators.
Possible mechanisms regulating the cellular localization and transcriptional
regulatory ability of CP2 family members were investigated by identification of non-
related binding proteins. Yeast-2-hybrid analysis identified Ubc9, PIAS1 and FKBP4 as
CRTR-I binding proteins. Ubc9 and PIASl function as regulators of post-translational
modification by sumoylation. These have been shown to regulate the cellular
localization and transcriptional regulation of other transcription factors, and were
shown here to interact with other mouse CP2 family members. In contrast the
immunophilin FKBP4 was determined to be a CRTR-I specific binding protein
suggesting that altemate mechanisms regulate CRTR-I and other family members.
il
Identification of CP2 farnlly member specific binding proteins suggest mechanisms for
independent regulation of CP2 family members through distinct cellular pathways.
Finally, identification of the sumoylation enhancer PIAS3 and transcription
factors Rexl and YYI as CRTR-I binding proteins provide further mechanisms for the
regulation of CRTR-1 activity through the control of cellular localization,
transcriptional regulation and promoter specificity and together suggest mechanisms for
the regulation of CRTR-I activity through signaling pathways important for
pluripotence and kidney development.
ilI
